Quoin Pharmaceuticals
QNRX
3 hedge funds and large institutions have $630K invested in Quoin Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
7% less capital invested
Capital invested by funds: $674K → $630K (-$44.3K)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$64K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$39K |
| 3 |
SPIA
Steward Partners Investment Advisory
New York
|
-$6.28K |
| 4 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $433K | – | – | – |
|
2
Citadel Advisors
Miami,
Florida
| $60K | – | – | – |
|
|
HF
3
HRT Financial
New York
| $48K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $38K | – | – | – |
|
5
UBS Group
Zurich,
Switzerland
| $31K | – | – | – |
|
6
Morgan Stanley
New York
| $20K | – | – | – |
|
|
TSS
7
Two Sigma Securities
New York
| – | -$39K | -1 | Closed |
|
|
VF
8
Virtu Financial
New York
| – | -$64K | -1 | Closed |
|
|
SPIA
9
Steward Partners Investment Advisory
New York
| – | -$6.28K | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| – | -$3K | – | – |
|
|
VFA
11
Valeo Financial Advisors
Carmel,
Indiana
| – | -$5K | – | – |
|
QNRX Hedge Fund Activity: Q2 2021 in Review
3 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q2 2021, worth a combined $630K — down 6.6% from $674K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of QNRX and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Virtu Financial, exiting entirely with an estimated $64K sold.
- 3 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q2 2021, down from 5 in Q1 2021.
- Funds reported $630K of Quoin Pharmaceuticals stock for Q2 2021, down 6.6% quarter-over-quarter.
- 0 funds opened new Quoin Pharmaceuticals positions in Q2 2021 and 2 closed out, a net change of -2 holders.
- The largest Quoin Pharmaceuticals seller in Q2 2021 was Virtu Financial, an estimated $64K sold.
Based on aggregated 13F filings for Q2 2021.